Interaction of alcoholic extracts of hops with pentobarbital and diazepam in mice

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 32, Issue 2, 2007, Pages 81-85

  Raskovic, Aleksandar ^a,c   Horvat, Olga ^a   Jakovljevic, Vida ^a   Sabo, Jan ^b   Vasic, Radica ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Scientific Institute of Field Crops and Vegetables   (Serbia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Alcoholic hops extracts; Aroma and wild genotype hops; Interaction with pentobarbital and diazepam; Magnum

Indexed keywords

ALCOHOL; AROMA HOPS EXTRACT; DIAZEPAM; MAGNUM HOPS EXTRACT; PENTOBARBITAL; PLANT EXTRACT; UNCLASSIFIED DRUG; WILD HOPS EXTRACT;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; BODY MOVEMENT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; COORDINATION; DRUG ANTAGONISM; DRUG MECHANISM; EVAPORATION; GENOTYPE; HOPS; MAGNUM; MEDICINAL PLANT; MOUSE; NONHUMAN; TRANQUILIZING ACTIVITY; WILD PLANT;

EID: 34547581727     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190996     Document Type: Article

References (9)

1. Fussel A., Wolf A., Brattstrom A. (2000): Effect of a fixed valerian-hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur. J. Med. Res.,5:385-390.
2. Schmitz M., Jackel M. (1998): Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops valerian preparation and a benzodiazepine drug. Wien. Med. Wochenschr.148:291-298.
3. Zanoli P., Rivasi M., Zavatti F., Brusiani M., Baraldi M. (2005): New insight in the neuropharmacological activity of Humulus lupulus L. J. Ethnopharmacol. 102: 102-106.
4. Hansel R., Wohlfart R., Coper H. (1980): Sedative-hypnotic compounds in the exhalation of hops. Z. Naturforsch. C. 35(11-12):1096-1097.
5. Wohlfart R., Wurm G., Hansel R., Schmidt H. (1983): Detection of sedative-hypnotic active ingredients in hops. 5. Degradation of bitter acids to 2-methyl-3-buten-2-ol, a hop constituent with sedative-hypnotic activity. , 316(2):132-137.
6. Sabo J., Jakovljevic V. (2006): Interaction of particular components of commercial beer and central action drugs. Exp. Pharmcol. (Novi Sad) (in Serbian).
7. Vogel G., Vogel R., Eds (1997): Drug discovery and evalution, Pharmacological assays. Springer Verlag, Berlin - New York.
8. Waller D.G., Renwick A.G., Hiller K. Eds (2005): Medical pharmacology and therapeutics, 2nd ed. Elsevier Saunders Edinburgh-Toronto, pp.269-274.
9. Schultz V., Hansel R., Tyler V.E. (2001): Rational phytotherapy. Springer Verlag, Berlin-New York.